IgG-based bispecific antibody that binds EGFR on tumor cells and CD28 on T cells to provide conditional CD28 costimulation only when both targets are engaged at the tumor site, enhancing T-cell activation, proliferation, cytokine release, and cytotoxicity against EGFR-positive tumors while limiting systemic immune activation.